AI Article Synopsis

  • The systematic review focuses on understanding attitudes and barriers related to preexposure prophylaxis (PrEP) and treatment as prevention (TasP) among transgender women and racial/ethnic-minority men who have sex with men (MSM), who are significantly impacted by HIV.
  • The review analyzed studies published between 2010 and 2019, identifying themes such as lack of awareness about PrEP and TasP, structural barriers to access, and stigma that adversely affect attitudes towards these prevention methods.
  • Despite some increase in PrEP use among at-risk individuals, misunderstanding of key concepts like "undetectable" and skepticism about TasP evidence hinder broader acceptance and could impede progress toward reducing HIV transmissions.

Article Abstract

Purpose: While the annual rate of new HIV infections and diagnoses has remained stable for most groups, troubling increases are seen in transgender women and racial/ethnic-minority men who have sex with men (MSM), groups that are disproportionately affected by HIV. The primary purpose of this systematic review is to examine factors that impact attitudes and beliefs about preexposure prophylaxis (PrEP) and treatment as prevention (TasP) and to explore barriers to PrEP uptake in MSM and transgender women.

Methods: Using MeSH terms and relevant keywords, we conducted a systematic review of studies published between 2010 and 2019. We searched 4 literature databases and identified studies on MSM and transgender women to elucidate perceptions of PrEP and TasP as well as barriers to access.

Results: The search yielded several prominent themes associated with beliefs about HIV prevention approaches and barriers to PrEP access in MSM and transgender women. One was a lack of awareness or insufficient knowledge of PrEP and TasP. Structural barriers and geographic isolation also prevent access to HIV prevention. Sexual minority and HIV-related stigma, internalized homonegativity, and misinterpretations of messages within HIV prevention campaigns have negatively impacted PrEP uptake and beliefs about PrEP and TasP. Quality of the relationship MSM or transgender people have with their health care provider can facilitate or hinder HIV prevention. Finally, variability in beliefs about the efficacy of TasP has negatively affected the impact of TasP messaging campaigns.

Conclusions: Although there is evidence of increasing PrEP use in at-risk individuals, several barriers prevent wider acceptance and uptake. Misunderstanding about the meaning of "undetectable" and skepticism about the evidence behind TasP messaging campaigns are likely to delay the World Health Organization's stated goal of getting to zero transmissions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398630PMC
http://dx.doi.org/10.17294/2330-0698.1737DOI Listing

Publication Analysis

Top Keywords

msm transgender
20
transgender women
16
hiv prevention
16
systematic review
12
prep tasp
12
preexposure prophylaxis
8
treatment prevention
8
men sex
8
sex men
8
men msm
8

Similar Publications

Over the past two decades, the global incidence of sexually transmitted infections (STIs) such as gonorrhea, chlamydia, and syphilis have increased significantly, particularly among cisgender men who have sex with men (MSM) and transgender women (TGW). This rise in STIs has spurred interest in new preventive measures, including doxycycline post-exposure prophylaxis (DoxyPEP). Clinical trials in the United States and France have demonstrated the effectiveness of DoxyPEP in reducing both chlamydia and syphilis incidence among MSM and TGW; although, its efficacy against gonorrhea remains limited, and it was further found to be ineffective among cisgender women in Kenya.

View Article and Find Full Text PDF

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends.

JAMA Intern Med

January 2025

San Francisco Department of Public Health, San Francisco, California.

Article Synopsis
  • The rising rates of sexually transmitted infections (STIs) have heightened health concerns, prompting research into doxycycline postexposure prophylaxis (doxyPEP) as a preventive strategy for bacterial STIs.
  • A study was conducted in San Francisco to evaluate how the introduction of doxyPEP guidelines affected reported cases of chlamydia, gonorrhea, and early syphilis among men who have sex with men (MSM) and transgender women.
  • Results revealed a significant decrease in STI cases among these populations after the implementation of doxyPEP guidelines, with chlamydia and early syphilis cases declining by 6.58% and 2.68% per month, respectively, compared to
View Article and Find Full Text PDF

Introduction: While African countries have expanded access to HIV pre-exposure prophylaxis (PrEP) since 2015, regional targets for PrEP uptake remain unmet. Understanding which populations are prioritized for PrEP at the policy level is an important step in determining the scope of PrEP distribution across Africa and identifying gaps in programme implementation. We reviewed national guidance to characterize populations prioritized for PrEP in Africa.

View Article and Find Full Text PDF

Background: Bacterial sexually transmitted infections (STIs) continue to increase in the United States. Despite evidence of the effectiveness of doxycycline post-exposure prophylaxis (Doxy-PEP) to prevent STIs, little is known about providers' attitudes and willingness to implement Doxy-PEP.

Methods: An online questionnaire was sent to 575 clinical providers in New York State in September 2022.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on understanding the stigma faced by MSM with HIV, transgender women with HIV, and healthcare providers in Dominican Republic healthcare settings.
  • Data was collected through focus groups and interviews, identifying four primary stigma themes: migrant stigma, religious stigma, SGM stigma, and HIV stigma.
  • The results highlight the severe impact of stigma on mental health, suggesting that effective interventions should tackle both structural barriers and cultural norms that contribute to stigma in HIV care.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!